The global leader in healthcare naming!

Including nonproprietary (USAN/INN) names, drug brand names, medical device names, OTC product names, and COVID-19 vaccines, repurposed drugs, and diagnostics! We name over 75% of nonproprietary (USAN/INN) and drug brand name approvals worldwide!

1154
Healthcare Clients
3972
Total Healthcare Names
16
Obesity Names
Animal Health - 27
Antibiotic - 101
Antifungal - 27
Antiviral - 117
Antiviral/HIV - 49
Biologic Suffix - 60
Biosimilar Name - 25
Cardiovascular - 193
Class Name - 9
Clinical Trial Name - 99
Corporate Identity - 117
COVID-19 - 31
Dermatology - 137
Division Identity - 16
Endocrinology - 180
Gastrointestinal - 110
Hematology - 137
Identity Research - 15
Immunology - 222
Medical Device - 263
Men's Health - 11
Metabolic Disorders - 61
Musculoskeletal - 34
Nephrology - 30
Neurology - 330
Nutritional Agent - 51
Obesity - 16
Oncology - 698
Ophthalmology - 128
Oral Care - 8
OTC - 136
Pain & Inflammation - 158
Product Identity - 7
Program Name - 18
Respiratory - 193
Service Name - 16
Tagline - 11
Technology Name - 34
Urology - 25
USAN/INN - 1290
Vaccine - 97
Website - 17
Women's Health - 136

* Denotes a comprehensive report of the safety regulatory research prepared by B/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

CLIENTNAMECATEGORY
ALIZYMECETILISTAT Obesity
CITIUS PHARMASUPRENZA Obesity
EISAIBELVIQ *Obesity
GSKALLI Obesity
JANSSENefinopegdutide Obesity
NOVO NORDISKSAXENDA *Obesity
OREXIGEN THERAPEUTICSCONTRAVE *Obesity
PFIZERREDUX Obesity
RHYTHM PHARMACEUTICALSIMCIVREE *Obesity
RIEMSERALVALIN Obesity
ROCHEXENICAL Obesity
SANOFIACOMPLIA *Obesity
SHIONOGI PHARMAvelneperit Obesity
TAKEDAOBLEAN (オブリーン) Obesity
VIVUSQSYMIA *Obesity
ZAFGENaclimostat Obesity